ABVC · Abvc Biopharma, Inc.
$1.02
-0.18 (-15.00%)
At close · Jul 27
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions give rise to substantial doubt as to whether the Company will be able to continue as a going concern.”View the 10-Q filed May 18, 2026
Market Cap
$29.90M
Shares
26.00M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$296K
-41.9%
FY2025
Net Income
-$7.91M
-61.3%
FY2025
Gross Margin
171.9%
+72pp
FY2025
Operating Margin
-2415.97%
-1492.6pp
FY2025
Diluted EPS
-$0.39
+7.1%
FY2025
Operating Cash Flow
-$2.99M
-65.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $296K | $509.59K | $152.43K | $969.78K | $355.8K | $483.05K | $701.72K | — | — | — | $3360 | — | $7787 | $5714 | $3190 | |
| — | $763 | $763 | $302.04K | $286.42K | $5086 | $18.72K | $20.14K | — | $32 | $32 | $521 | — | — | — | — | |
| — | $508.83K | $508.83K | -$149.61K | $683.37K | $350.71K | $464.33K | $681.58K | — | -$32 | -$32 | $2839 | — | — | — | — | |
| — | 171.9% | 99.85% | -98.15% | 70.47% | 98.57% | 96.13% | 97.13% | — | — | — | 84.49% | — | — | — | — | |
| $125.32K | $121.09K | $179.27K | $1.06M | $2.69M | $1M | $549.66K | $1.05M | $669.67K | $3.15M | $10M | — | — | — | — | — | |
| $1.46M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $1.89M | |
| $3.02M | $2.89M | $2.26M | $5.37M | $6.07M | $5.75M | $4.27M | $3.07M | $695.15K | $707.14K | $997.26K | — | — | — | — | — | |
| $27.38K | — | — | — | $23.8K | — | — | — | — | — | — | — | — | $23.86K | $33.05K | $34.18K | |
| $8.03M | $7.15M | $5.21M | $8.07M | $15.8M | $12.06M | $8.97M | $4.14M | $1.39M | — | — | $35.12K | — | $185.05K | $1.15M | — | |
| -$8.03M | -$7.15M | -$4.71M | -$8.22M | -$15.11M | -$11.71M | -$8.51M | -$3.46M | -$1.39M | -$4M | -$11M | — | — | -$177.26K | -$1.14M | -$1.89M | |
| — | -2415.97% | -923.34% | -5390.35% | -1558.54% | -3290.07% | -1760.87% | -492.9% | — | — | — | — | — | -2276.35% | -20004.31% | -59180.66% | |
| -$9.36M | — | — | — | -$15.09M | — | — | — | — | — | — | — | — | -$153.4K | -$1.11M | -$1.85M | |
| $242.3K | $415.89K | $825.9K | $2.49M | $293.97K | $227.21K | $405.03K | $482.01K | $155.93K | $74.96K | $10.17K | $0 | — | $49.09K | $87.7K | -$204.92K | |
| $151.8K | $167.1K | $87.36K | $185.48K | $187.82K | — | $71.05K | $23.34K | $93 | $149 | $361 | — | — | — | — | — | |
| -$1.07M | -$1.2M | -$664.33K | -$2.44M | -$400.18K | $495.14K | -$2.31M | -$551.5K | -$2.71M | -$74.81K | -$9668 | — | — | -$49.09K | $141.1K | — | |
| -$783.55K | -$803.01K | — | -$221.89K | -$269.84K | — | — | -$210.09K | -$2.55M | — | — | — | — | — | — | — | |
| — | -$192.76K | -$339.17K | -$7446 | — | — | -$40.59K | -$395.48K | -$549 | — | — | — | — | — | — | — | |
| -$9.1M | -$8.35M | -$5.37M | -$10.65M | -$15.51M | -$11.21M | -$10.81M | -$4.01M | -$4.1M | -$4.07M | -$11.01M | — | — | — | — | — | |
| — | $24.15K | -$110.54K | $256.01K | $797.78K | $825.02K | -$220.35K | -$77.04K | $1850 | $830 | $836 | — | — | $0 | $67.64K | — | |
| -$8.63M | -$7.91M | -$4.9M | -$10.52M | -$16.42M | -$12.04M | -$10.59M | -$3.93M | -$4.1M | -$4.07M | -$11.01M | -$32.28K | -$70 | -$226.35K | -$1.07M | -$1.22M | |
| — | -2671.81% | -962.12% | -6898.68% | -1693.5% | -3382.79% | -2193.08% | -560.51% | — | — | — | -960.74% | — | -2906.79% | -18718.57% | -38202.23% | |
| -$495.99K | -$468.41K | -$356.16K | -$394.63K | $110.87K | -$12.04M | — | — | — | — | — | — | — | — | — | — | |
| $9.13M | — | $5.26M | — | -$16.42M | -$12.84M | — | — | — | — | — | — | — | -$236.4K | -$1.54M | -$3.01M | |
| -$8.57M | -$7.87M | -$4.97M | -$10.52M | -$16.45M | -$12.86M | -$9.89M | -$3.63M | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$0.39 | -$0.42 | -$2.43 | -$5.20 | -$5.10 | — | — | -$0.20 | -$0.20 | -$0.60 | — | — | — | — | — |
| USD/shares | — | -$0.39 | -$0.42 | -$2.43 | -$5.00 | -$5.10 | — | — | -$0.20 | -$0.20 | -$0.60 | — | — | — | — | — |
| shares | — | 20.11M | 11.67M | 4.34M | 3.17M | 2.51M | 1.97M | 1.75M | 21.39M | 21.26M | 19.4M | 500.09K | — | 5.46M | 2.89M | 973.82K |
| shares | — | 20.11M | 11.67M | 4.34M | 3.02M | 2.51M | 1.97M | 1.75M | 21.39M | 21.26M | 19.4M | 500.09K | — | 5.46M | 2.89M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 12.94×
EV/EBIT
—
P/E (TTM)
—
Peer median 0.94×
Peer medians compare against the 267 similar-size Biotechnology companies (of 521 listed).